Positron emission tomography and single photon emission CT molecular imaging in schizophrenia (Q35692963)

9 August 2017

1 reference

title

Positron emission tomography and single photon emission CT molecular imaging in schizophrenia (English)

1 reference

positron emission tomography

9 August 2017

1 reference

1 reference

1

David Erritzoe

0 references

Anissa Abi-Dargham

series ordinal

4

object named as

Anissa Abi-Dargham

1 reference

9 August 2017

Peter Talbot

2

1 reference

9 August 2017

W Gordon Frankle

series ordinal

3

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Neuroimaging clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

13

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

817-832

1 reference

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine, the prefrontal cortex and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Functional and anatomical aspects of prefrontal pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

The nature of interactions involving prefrontal and striatal dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Molecular cloning and expression of the gene for a human D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Cloning and expression of human and rat D1 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopaminergic systems. Dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine receptor mRNA expression in human striatum and neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine D2 receptors in schizophrenia studied in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Imaging D2 receptor occupancy by endogenous dopamine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Evidence for a widespread dopaminergic innervation of the human cerebral neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

[123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Probing targets for antipsychotic drug action with PET and SPET receptor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Sertindole and dopamine D 2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123 I-IBZM SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Limbic selectivity of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Dopamine receptor occupancy and plasma haloperidol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

The role of model-based methods in the development of single scan techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900089-3

7 January 2021

10.1016/S1052-5149(03)00089-3

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uopv7gg2fjcnbmifh3qytwqqty

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_uopv7gg2fjcnbmifh3qytwqqty

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uopv7gg2fjcnbmifh3qytwqqty

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/uopv7gg2fjcnbmifh3qytwqqty

1 reference

30 July 2022